LAZARUS, G.; AUDREY, J.; ISKANDAR, A. Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: A comprehensive systematic review. Oncology Reviews, v. 13, n. 2, 10 out. 2019.